Related Experiment Video
Updated: Jun 13, 2026
06:15
Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
Stability of IgG isotypes in serum
1Abbott Bioresearch Center, Worcester, MA, USA. Ivan.Correia@Abbott.com
Mabs
|April 21, 2010
Summary
Selecting therapeutic antibody isotypes requires careful consideration of effector function and stability. Understanding how immunoglobulin isotypes change in serum is crucial for effective drug development and improved therapeutic potency.
Area of Science:
- Biopharmaceutical development
- Immunology
- Protein engineering
Background:
- Drug development involves selecting specific immunoglobulin isotypes for therapeutic use, with IgG1 being most common among approved monoclonal antibodies.
- While analytical techniques assess antibody stability in vitro, therapeutic molecules recovered from patient serum often exhibit altered physicochemical properties and reduced potency.
- Recent approvals of non-IgG1 antibodies and increasing development signal a need for broader isotype considerations.
Purpose of the Study:
- To review studies on physicochemical changes in antibody therapeutics recovered from circulation.
- To highlight technologies for rapid screening of antibody candidates directly from blood.
- To emphasize the importance of understanding isotype biology and serum stability in therapeutic development.
Main Methods:
- Review of existing literature on antibody therapeutics in circulation.
- Analysis of physicochemical changes in recovered antibody molecules.
- Identification and discussion of technologies for direct-from-blood screening.
Main Results:
- Antibody therapeutics recovered from serum often display altered physicochemical characteristics compared to in vitro assessments.
- Reduced potency is frequently observed in therapeutic molecules isolated from patient blood.
- Physicochemical changes are linked to the in vivo environment, specifically serum.
Conclusions:
- Antibody therapeutic development must account for the inherent stability and biological behavior of selected immunoglobulin isotypes within the serum environment.
- Understanding serum stability is critical for predicting and ensuring therapeutic efficacy.
- Incorporating in vivo stability assessments early in development can optimize candidate selection and improve outcomes.
More Related Videos
Related Concept Videos
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:25Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...